{"id":812,"date":"2010-09-03T15:37:15","date_gmt":"2010-09-03T19:37:15","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=812"},"modified":"2010-09-03T15:39:53","modified_gmt":"2010-09-03T19:39:53","slug":"small-business-grant-given-for-cancer-drug-delivery-system","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=812","title":{"rendered":"Small Business Grant Given for Cancer Drug Delivery System"},"content":{"rendered":"<p><a href=\"http:\/\/www.celsion.com\/\">Celsion Corp.<\/a>, a biotechnology drug development company in Columbia, Maryland, has received a Phase 1 Small Business Innovation and Research (SBIR) grant from the National Institutes of Health. This funding will help the company develop its heat-activated liposomal &#8212; encapsulated cellular membrane sac &#8212; technology in combination with <a href=\"http:\/\/www.mayoclinic.com\/health\/drug-information\/DR600307\">carboplatin<\/a>, a frequently used oncology drug for treatment of a wide range of cancers.<\/p>\n<p>The grant is valued at approximately $200,000 and will support formulation development and preclinical efficacy studies with Duke University. Phase 1 SBIR grants fund feasibility and proof-of-concept studies.<\/p>\n<p>Celsion develops cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion&#8217;s lead product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, a cancer chemotherapy drug. ThermoDox is currently in a phase 3 clinical trial for the treatment of liver cancer (hepatocellular carcinoma) and in a Phase 1\/2 trial for patients with recurrent chest wall breast cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Celsion Corp., a biotechnology drug development company in Columbia, Maryland, has received a Phase 1 Small Business Innovation and Research (SBIR) grant from the National Institutes of Health. This funding will help the company develop its heat-activated liposomal &#8212; encapsulated cellular membrane sac &#8212; technology in combination with carboplatin, a frequently used oncology drug for [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[21,51,38,39],"class_list":["post-812","post","type-post","status-publish","format-standard","hentry","category-finance","tag-biotech","tag-cancer","tag-grant","tag-nih"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=812"}],"version-history":[{"count":4,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/812\/revisions"}],"predecessor-version":[{"id":816,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/812\/revisions\/816"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}